Title |
Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial |
|---|---|
Involved |
Ulrike Nitz (Verfasser)
Oleg Gluz (Sonstige) Matthias Christgen (Sonstige) Ronald E. Kates (Sonstige)
Michael Clemens (Sonstige)
Wolfram Malter (Sonstige) Benno Nuding (Sonstige) Bahriye Aktas (Sonstige) Sherko Kuemmel (Sonstige) Toralf Reimer (Sonstige) Andrea Štefek (Sonstige) Fatemeh Lorenz-Salehi (Sonstige) Petra Krabisch (Sonstige) Marianne Just (Sonstige) Doris Augustin (Sonstige) Cornelia Kolberg-Liedtke (Sonstige) Calvin Chao (Sonstige) Steven Shak (Sonstige) Rachel Wuerstlein (Sonstige) Hans H. Kreipe (Sonstige) Nadia Harbeck (Sonstige) SpringerLink (Online service) (Sonstige) |
Published in |
Breast cancer research and treatment 165, 3, 29.6.2017, date:10.2017, Seite 573-583 |
Published |
2017 |
Language |
|
Country |
|
Topic |
|
Subject |
|
DDC notation |
|
Persistent identifier |
urn:nbn:de:1111-201711173824 (URN) |
Record ID |
1144617626 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: